)
CHINA NATIONAL MEDICINES CORP (600511) investor relations material
CHINA NATIONAL MEDICINES CORP Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 2026 revenue was RMB 13.878bn, up 0.95% YoY; net income attributable to shareholders was RMB 596.5m, up 9.70%.
For 9M 2026, revenue rose 3.11% YoY to RMB 40.606bn, while attributable net income fell 1.07% to RMB 1.476bn.
Financial highlights
Q3 profit before tax was RMB 765.4m, up 8.24% YoY; adjusted attributable net income was RMB 595.7m, up 10.59%.
9M profit before tax declined 1.32% YoY to RMB 1.908bn; adjusted attributable net income edged up 0.36% to RMB 1.475bn.
9M consolidated net income was RMB 1.490bn versus RMB 1.556bn a year earlier; operating revenue was RMB 40.606bn versus RMB 39.381bn.
9M investment income was RMB 424.5m, including RMB 394.2m from associates and joint ventures, versus RMB 441.0m and RMB 411.1m, respectively, a year earlier.
Key financial ratios and metrics
Q3 basic and diluted EPS were RMB 0.7906, up 9.71% YoY; 9M EPS was RMB 1.9566, down 1.07%.
Weighted average ROE was 3.12% for Q3, up 0.06 percentage points YoY, and 7.79% for 9M, down 0.71 percentage points.
Total assets were RMB 36.813bn at Sep. 30, 2026, up 0.35% from year-end 2025; equity attributable to shareholders was RMB 19.408bn.
- Revenue up 4.27% YoY, but net profit down 7.25% amid margin pressure and policy headwinds.600511
Q2 2026 - Revenue and net profit rose year-over-year, but operating cash flow remained negative.600511
Q1 2026 - Q3 profit and EPS rose over 13% year-over-year, but operating cash flow stayed negative.600511
Q3 2025 - Revenue up 3.54% but net profit down 5.19% amid industry reform and strong distribution.600511
Q2 2025 - Revenue and net profit rose modestly, but operating cash flow turned negative.600511
Q3 2024 - Revenue and net profit grew modestly, with stable distribution but industrial headwinds.600511
Q2 2024 - Revenue up 4.87% in Q1 2025, but net profit and ROE slightly declined.600511
Q1 2025 - Revenue up 1.81%, net profit down 6.80%, with strong market share and digital transformation.600511
Q4 2024
Next CHINA NATIONAL MEDICINES CORP earnings date
Next CHINA NATIONAL MEDICINES CORP earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage
)